CLX vs REPL · P/E 15, rev $7.10B vs $825.7M cap
The Clorox Company (CLX) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. Revenue was up 0.2% from 2024-06-30 to 2025-06-30. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
REPL does not have a complete income-statement cache yet.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. REPL currently screens at market cap $825.7M.
Not investment advice. Open the CLX and REPL stock pages for the full models.
Not investment advice.